Table 1.
Patient Characteristics | 1 | 2 | 3 | 4 | 5 | 6 | |
---|---|---|---|---|---|---|---|
Total | HPV+ Nonsmokers | HPV+ Smokers | HPV− Patients | p-Values HPV+ vs. HPV− (n = 57 vs. n = 34) | p-Values Smokers vs. Nonsmokers (n = 69 vs. n = 22) | ||
n = 91 | n = 20 | n = 37 | n = 34 | ||||
Age at diagnosis of index tumor | Median (y) | 59.54 | 58.2 | 58.7 | 57.6 | 0.483 | 0.646 |
IQR | 52.7–65.6 | 52.8–66.7 | 51.0–67.3 | 53.8–65.1 | |||
Sex | |||||||
male | n (%) | 68 (74.7%) | 14 (70%) | 28 (75.7%) | 26 (76.5%) | 0.809 | 0.413 |
female | n (%) | 23 (25.3%) | 6 (30%) | 9 (24.3%) | 8 (23.4%) | ||
History of alcohol abuse | n (%) | 28 (30.8%) | 0 | 9 (24.3%) | 19 (55.9%) | 0.000 * | 0.000 * |
Index-OPSCC localization |
|||||||
Tonsils | n (%) | 79 (86.8%) | 19 (95%) | 34 (91.9%) | 26 (76.6%) | 0.050 * | 0.281 |
Base of tongue | n (%) | 9 (9.9%) | 1 (5%) | 3 (8.1%) | 5 (14.7%) | 0.286 | 0.446 |
Soft palate | n (%) | 1 (1.1%) | - | - | 1 (2.9%) | - | - |
Pharyngeal wall | n (%) | 2 (2.2%) | - | - | 2 (5.9%) | - | - |
Death due to OPSCC or associated cancer | n (%) | 17 (18.7%) | 2 (10%) | 5 (13.4%) | 10 (29.4%) | 0.054 | 0.226 |
Index-UICC stadium | |||||||
I | n (%) | 15 (16.5%) | 3 | 5 | 7 | 0.56 | 1 |
II | n (%) | 17 (18.7%) | 5 | 6 | 6 | 1 | 0.345 |
III | n (%) | 11 (12.1%) | 0 | 4 | 7 | 0.093 | 0.06 |
IVa | n (%) | 47 (51.6%) | 12 | 22 | 13 | 0.055 | 0.47 |
IVb | n (%) | 1 (1.1%) | 0 | 0 | 1 | - | - |
Treatment | |||||||
Surgery | n (%) | 91 (100%) | 20 (100%) | 37 (100%) | 34 (100%) | 1 | 1 |
RT ± chemo | n (%) | 60 (65.9%) | 13 (65%) | 25 (67.6%) | 21 (61.8%) |